85
Participants
Start Date
May 31, 2009
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Topiramate
Topiramate will be administered orally twice daily beginning on Day 1, Week 1 and continue through Day 7, Week 14. Subjects will be dose titrated as tolerated to a target doses 300 mg topiramate.
Zonisamide
Zonisamide will be administered orally twice daily beginning on Day 1, Week 1 and continue through Day 7, Week 14. Subjects will be dose titrated as tolerated to a target doses of 2000 400 mg of zonisamide.
Levetiracetam
Levetiracetam will be administered orally twice daily beginning on Day 1, Week 1 and continue through Day 7, Week 14. Subjects will be dose titrated as tolerated to a target doses of 2000 mg levetiracetam capsules.
Sugar Pill
Matched placebo will be administered orally twice daily beginning on Day 1, Week 1 and continue through Day 7, Week 14.
Boston University School of Medicine, Boston
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Boston Medical Center
OTHER